VVOS logo

Vivos Therapeutics (VVOS) Enterprise Value

Enterprise Value

$15.59 M
+$338.47 K+2.22%

Fri, 07 Feb 2025 22:53:47 GMT


Summary


Performance

VVOS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherVVOSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

VVOS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+2.2%+1.7%+1.7%
1 m1 month-6.1%-4.8%-4.8%
3 m3 months+82.8%+53.5%+51.3%
6 m6 months+565.1%+170.7%+90.5%
ytdytd-7.2%-5.6%-5.6%
1 y1 year+58.0%+112.9%-19.3%
5 y5 years---

VVOS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-39.3%$14 M+12.6%
3 m3-month$26 M-39.3%$8.53 M+82.8%
6 m6-month$26 M-39.3%$2.07 M+652.4%
1 y1-year$26 M-39.3%$1.80 M+766.2%
3 y3-year$61 M-74.5%$1.80 M+766.2%
5 y5-year$163 M-90.5%$1.80 M+766.2%
alltimeall time$163 M-90.5%$1.80 M+766.2%

Vivos Therapeutics Enterprise Value History

DateValue
2025
$15.59 M(-7.2%)
2024
$16.80 M(-26.7%)
2023
$22.91 M(+181.3%)
DateValue
2022
$8.15 M(-72.3%)
2021
$29.38 M(-67.6%)
2020
$90.71 M

FAQ

  • What is Vivos Therapeutics enterprise value?
  • What is the all time high enterprise value for Vivos Therapeutics?
  • What is VVOS enterprise value year-to-date change?
  • What is Vivos Therapeutics enterprise value year-on-year change?

What is Vivos Therapeutics enterprise value?

The current enterprise value of VVOS is $15.59 M

What is the all time high enterprise value for Vivos Therapeutics?

Vivos Therapeutics all-time high enterprise value is $163.32 M

What is VVOS enterprise value year-to-date change?

Vivos Therapeutics enterprise value has changed by -$1.21 M (-7.20%) since the beginning of the year

What is Vivos Therapeutics enterprise value year-on-year change?

Over the past year, VVOS enterprise value has changed by +$5.72 M (+57.97%)